Neurodegenerative movement disorders like Parkinson's disease are currently diagnosed via the patient's clinical symptoms, without biomarkers.A study of more than 3000 donated brains from brain banks across the world, analysed genetic material and showed misdiagnosis rates of between 10 and 20 percent. Researchers hope to use these results to create clinical trials that will improve diagnostic accuracy. Guest/sClaire Shepherd, Director of the Sydney Brain Bank at Neuroscience Research Australia and Conjoint Associate Professor in Pathology, UNSW ReferencesPathology and Genetics in a Global Cohort of Parkinsonian Disorders

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related